ArticleInternational journal of molecular sciences2026
Neural Network-Based System for Rapid Diagnostic Decision Support Using FLIM Data: Segmentation and Classification in Liver, Skin, and Pancreatic Tissues.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Fluorescence lifetime imaging microscopy (FLIM) is a powerful tool for analyzing metabolic changes by measuring the fluorescence lifetime of endogenous fluorophores such as the reduced form of nicotinamide adenine dinucleotide (phosphate) (NAD(P)H), enabling differentiation between normal and pathological states in diverse tissues. However, traditional manual FLIM data processing suffers from several drawbacks, including subjective selection of regions of interest, variability in analysis parameters, time-consuming procedures, and inherent human bias. To address these limitations, we developed an automated pipeline that leverages multiple pre-trained foundational models-SAM 2, CellposeSAM, LACSS, and CellSAM-for rapid, intensity-based segmentation and subsequent classification of the FLIM parameters in liver, pancreas, and skin tissues. Our comparative analysis identified the most suitable models for each tissue type and, crucially, enabled accurate discrimination between normal and pathological conditions. SAM 2 and LACSS demonstrated stable segmentation performance across both healthy and diseased tissues, though with distinct strengths: SAM 2 excelled at segmenting large structures (e.g., entire pancreatic islets of Langerhans, or very large cells), whereas LACSS was more effective for small structures. In contrast, CellposeSAM and CellSAM yielded less consistent segmentation overall but achieved notably high efficiency in specific cases. These findings establish a foundation for the rapid, automated discrimination of normal versus pathological tissues, offering a robust complement to existing clinical methods and to FLIM workflows for research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.